Miguel Cruz

Cruz

Miguel Cruz, Ph.D.

Professor and Division Chief

(713) 794-7775

Positions

Professor and Division Chief
Medicine
Thrombosis Research
Baylor College of Medicine
Houston, Texas, US
Co-Director
Center for Translational Research on Inflammatory Diseases (CTRID)
Michael E. DeBakey VA Medical Center
Baylor College of Medicine
Houston, Texas, United States
Research Health Scientist
Research Service Line
Michael E. DeBakey VA Medical Center
Houston, Texas, United States
Member
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Addresses

Center for Translational Research on Inflammatory Diseases (CTRID) (Lab)
Michael E. DeBakey VA Medical Center
2002 Holcombe Blvd.
Houston, TX, 77030
United States
Phone: (713) 794-7775
miguelc@bcm.edu
Center for Translational Research on Inflammatory Diseases (CTRID) (Office)
Michael E. DeBakey VA Medical Center
2002 Holcombe Blvd.
Houston, TX, 77030
United States
Phone: (713) 794-7775
miguelc@bcm.edu

Education

PhD from University Of Puerto Rico School Of Medicine, Rio Piedras, Pr
01/1989 - Rio Piedras, PR
Biochemistry
Postdoctoral Fellowship at Harvard Medical School
01/1994 - Boston, Massachusetts, United States
Protein Biochemistry - Hematology
BS from University Of Puerto Rico, Rio Piedras, Puerto Rico
Rio Piedras, PR
Chemistry
Advanced Training from Brigham And Women's Hospital
01/1994 - Boston, MA, United States

Professional Interests

  • Thrombosis, von Willebrand factor, platelet adhesion, DIC, extracellular hemoglobin, inflammation, vimentin, translational medicine

Selected Publications

Memberships

International Society of Hemostasis and Thrombosis

Funding

Microvascular Thrombosis in systemic inflammation
#R01GM112806
$1,522,000.00   (09/25/2014 - 05/31/2025)
Grant funding from NIH
Molecular Studies of Hemolytic Thrombosis
#R01HL154688
$1,880,000.00   (05/14/2021 - 04/30/2025)
Grant funding from NIH
Collaborative Research Training in Thrombosis and Inflammation
$1,693,400.00   (08/01/2018 - 07/31/2023)
Grant funding from NIH

Intellectual Property

Treatment of medical condition with A2 domain of von Willebrand factor
Product Patent #7879793 (Approved)

Languages

Spanish

Log In to edit your profile